Cognetivity Neurosciences  logo

Cognetivity Neurosciences

Cognetivity Neurosciences Ltd. is a healthcare company, which engages in the development of an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia. The company was founded by Simone Ivonne Reinders and David Gill in 2017 and is headquartered in London, the United Kingdom.

Latest events on Quartr

Previous Events for Cognetivity Neurosciences




About the company

Investor Relations page

Dig deeper into the fundamentals using Quartr - Investor relations

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
Android play link
App store link
Quartr app screenshot